A cold start for oral glycoprotein IIb/IIIa antagonists
- PMID: 11102247
- DOI: 10.1053/euhj.2000.2458
A cold start for oral glycoprotein IIb/IIIa antagonists
Comment on
-
Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study.Eur Heart J. 2000 Dec;21(24):2042-55. doi: 10.1053/euhj.2000.2309. Eur Heart J. 2000. PMID: 11102255 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
